Dixon Tech price targets 2026: 29 analysts map levels

Why Dixon Technologies is back in focus

Dixon Technologies’ share price saw sharp intraday moves amid renewed market chatter that the government could be close to clearing the company’s long-pending joint venture with Chinese smartphone maker Vivo. Multiple brokerage notes during the period kept the spotlight on how the proposed JV could reshape Dixon’s mobile phone manufacturing scale in India.

The near-term trading action also brought the broader analyst universe into focus, with the 12-month consensus target and the spread between high and low estimates showing how divided expectations remain.

Vivo JV approval reports drive the day’s narrative

Fresh reports suggested government approval for the Dixon-Vivo JV could be imminent. NDTV Profit cited an update that an inter-ministerial committee gave the nod after a meeting on Saturday, while noting that the government was yet to confirm the approval.

Brokerages framed the potential approval as a key event because it could shift a large share of Vivo’s India manufacturing into the JV structure. JPMorgan linked this directly to scale opportunity in Dixon’s mobile and EMS business, aligning the thesis with the broader Make in India push.

How the stock traded across key sessions

On one trading session cited in the text, Dixon Technologies shares were reported at ₹12,201 on the NSE, up about 0.95% from the previous close of ₹12,086, and touched an intraday high of ₹12,284.

In a separate update, the stock rose more than 3% intraday after reports of imminent approval. It touched an intraday high of ₹12,210 before easing to around ₹11,925, still higher on the day.

Another cited session on June 17, 2026 saw Dixon Tech gain about 5.24% to ₹12,876, with a day high of ₹12,888. A related market update reported the stock hit an intraday high of ₹12,859 and was up about 4.5% at ₹12,782 at the time of writing.

The broader context: 52-week range and consensus target spread

The article data places Dixon Tech’s 52-week range between ₹9,600 and ₹18,471, highlighting the volatility investors have navigated in the last year.

On analyst expectations, projections from 29 analysts put the average 12-month price target at ₹12,060.41, with a high estimate of ₹16,200 and a low estimate of ₹8,157. Based on the stated consensus, the stock had a potential downside of -8.92% versus the analysts’ average price target.

Summary table: key market and estimate datapoints

JM Financial’s upgrade: Buy, higher target price

JM Financial Institutional Securities upgraded Dixon Technologies to ‘Buy’ from ‘Add’ and raised its target price by 27% to ₹14,200 from ₹11,200. The brokerage cited improved visibility on the Vivo JV as part of its rationale.

The same note also pointed to higher average smartphone selling prices and steady progress in Dixon’s IT hardware business, naming clients such as HP, Lenovo, Acer and Asus.

JPMorgan’s view: volumes, upgrades, and a higher “fair value”

JPMorgan maintained an Overweight/overweight stance in the updates cited, with an unchanged target price of ₹12,700 in multiple references. It highlighted the scale opportunity from moving a large share of Vivo’s India manufacturing into the JV structure.

As per the cited projections, the JV could contribute 11 million units to mobile volumes in FY27 and 22 million units in FY28. The same JPMorgan update said this could drive a 24% to 39% upgrade to revenue estimates over the period and a 13% to 18% upgrade to EPS, taking “fair value” to ₹15,100 (as stated in the text).

Separately, the June 17 context also referenced a JPMorgan target of ₹13,000, described as revised from an earlier ₹13,700, alongside a note that the brokerage trimmed earnings estimates.

Other brokerage calls and price targets cited

Beyond JM Financial and JPMorgan, several brokerages were referenced with updated targets or ratings. UBS upgraded Dixon Technologies to a ‘Buy’ rating with a target price of ₹23,000, described as implying around 27% upside in the provided context. Macquarie was cited with a ‘Buy’ and a target of ₹15,000, while Nomura/Instinet was listed with a ‘Buy’ and a target of ₹13,813.

Another brokerage view in the text said Motilal Oswal Financial Services reiterated ‘Buy’ with a target price of ₹14,700, referenced against a previous close of ₹11,287. HSBC was cited with a ‘hold’ call and a target of ₹11,500. Mirae Asset Sharekhan was cited with a target of ₹14,400, while BOB Capital was cited with a target of ₹11,400.

Comparison table: brokerage targets mentioned

What the “fair value” range implies without approval

One market comment cited in the text framed a “fair value” trading range of ₹12,000 to ₹12,500 in the absence of Vivo approval. This reference matters because it separates the base-case trading band from any re-rating linked to the JV becoming official.

In parallel, the same broader narrative includes the view that once the Vivo JV is approved, some brokerages see scope for re-rating, even where the stated target price appears closer to prevailing prices.

Market impact: what investors are tracking next

The key market variable remains the status and timing of the government’s confirmation on the Dixon-Vivo JV. Several notes linked the event directly to future volume contribution, with projections ranging up to 22 million units by FY28 in one cited JPMorgan view.

JM Financial also laid out an additional unit ramp perspective, estimating that nearly two-thirds of Vivo’s annual India volumes of 35 to 37 million smartphones could eventually be manufactured through the joint venture, translating to roughly 22 to 24 million units of additional annual production capacity for Dixon.

Operational timing was also referenced, with one line stating that operations are expected to start in Q3 FY27.

Conclusion

Dixon Technologies’ recent moves were closely tied to reports that the government may be nearing a decision on the Vivo JV, an event that brokerages link to higher mobile volumes and potential estimate upgrades. Analyst targets remain widely dispersed, with the 29-analyst average at ₹12,060.41 and estimates spanning ₹8,157 to ₹16,200.

The next decisive trigger in the narrative is a confirmed government update on the JV and any follow-through disclosures on timelines and production scale, including the cited expectation of operations beginning in Q3 FY27.